HeyJaredM. V. Cunha's Substack
Long-term investor. BSc in Economics, MSc in Finance. Equity Analyst with a focus on Fundamental Analysis and Valuation. Not a financial advisor.
- Indexed issues, last 90 days
- 14
- Latest publication
- Sep 30, 2026
- Audience
- Checking…
- Earliest in this view
- Aug 11, 2026
Latest issues
Free Portfolio Update: Recap of Q3 2026 (opens the original)
Read excerpt
As promised, I’ll continue sharing a public recap at the end of each quarter.Two weeks ago, I published a Portfolio Update covering my latest thoughts on each holding and plans going forward.This one is more straightforward: a transparent summary of all transactions made during Q3.As previously mentioned, portfolio updates throughout the quarter will remain exclusive to paid members.Performance OverviewFor reference, here’s my performance so far:2024 Returns: +173.0%<l
4 AI Stocks I Like But Don’t Own (and Why) (opens the original)
Read excerpt
Finding stocks I like isn’t particularly difficult. Finding stocks I like enough to actually put in my portfolio is a very different story.I follow a large number of companies that I think are genuinely interesting, but I don’t own them all.Every dollar I invest in one company is a dollar I can’t invest somewhere else. Valuation matters. Management matters. Existing portfolio exposure matters. Geography matters. And sometimes a company can check almost every box and still not offer enough upside
Deep Dive: The AI Healthcare Stock No One Is Talking About (opens the original)
Read excerpt
For a long time, I’ve been trying to find an underfollowed public company sitting at the intersection of AI and healthcare.If you’ve followed me for a while, you probably remember that at the beginning of this year I pitched Twist Bioscience (TWST) while the stock was still trading in the $30s. I found the story fascinating and, for the first time, felt genuinely excited about a company exposed to this emerging theme.The problem was valuation. I became too picky and convinced myself I’d get a be
Portfolio Update – 09/18/2026: Updated Thoughts on Each Holding & Current Plans (opens the original)
Read excerpt
It’s been a month since my last portfolio update, so it’s time for another one.In this article, I’ll cover the changes I’ve made over the past few weeks and share my updated thoughts on each of my holdings. I’ll also look at which stocks I’m most likely to add to at current levels, some potential new positions I may start in the near term, and how I’m thinking about the portfolio as a whole going forward.As previously mentioned, portfolio updates throughout the quarter will remain exclusive to p
Omada Health (OMDA): Thesis Update After Investor Day (opens the original)
Read excerpt
Last week, Omada held its first Investor Day as a public company.I’ve written extensively about it since initiating my position in December, including reviews of every earnings report since then, so I’m not going to spend this article repeating the entire thesis or explaining the business model again. If you’re new to the company, I’d recommend starting with my original Deep Dive.Instead, I want to focus on what was actually new.The core thesis remains the same: Omada spent more than a decade bu
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.